CONSOLIDATED STATEMENTS OF CASH FLOWS - USD ($) $ in Thousands	6 Months Ended
	Nov. 02, 2025	Oct. 27, 2024
Cash flows from operating activities:
Net loss	$ (4,537)	$ (12,905)
Adjustments to reconcile net loss to net cash used in operating activities:
Depreciation	2,168	3,077
Non-cash inventory charge (credit)	976	(309)
Amortization	192	200
Stock-based compensation	333	364
Deferred income taxes	412	204
Gain sale of equipment	(4)	(27)
Realized gain on sale of invesments (rabbi trust)	(3)
Non-cash restructuring (credit) expense	(3,601)	2,178
Foreign currency exchange loss	518	237
Changes in assets and liabilities:
Accounts receivable	1,240	(1,162)
Inventories	(1,512)	117
Other current assets	494	194
Other assets	104	107
Accounts payable – trade	2,065	6,506
Deferred revenue	467	(366)
Accrued restructuring	(328)	875
Accrued expenses and deferred compensation	376	(738)
Income taxes	(526)	(1,185)
Net cash used in operating activities	(1,166)	(2,633)
Cash flows from investing activities:
Capital expenditures	(218)	(1,578)
Proceeds from the sale of property, plant, and equipment	979	527
Proceeds from notes receivable	180	180
Proceeds from the sale of investments (rabbi trust)	479	462
Purchase of investments (rabbi trust)	(254)	(378)
Net cash provided by (used in) investing activities	1,166	(787)
Cash flows from financing activities:
Procceds from line credit	8,049	4,010
Payments on lines of credit	(2,715)
Payment of debt issuance costs	(169)
Common stock surrendered for withholding taxes payable	(76)	(68)
Net cash provided by financing activities	5,089	3,942
Effect of foreign currency exchange rate changes on cash and cash equivalents	10	(3)
Increase in cash and cash equivalents	5,099	519
Cash and cash equivalents at beginning of period	5,629	10,012
Cash and cash equivalents at end of period	$ 10,728	$ 10,531